01 1Sun Pharmaceutical Industries Limited
01 1RIFAXIMIN PROCESS II
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-09-03
Pay. Date : 2019-05-09
DMF Number : 33833
Submission : 2019-07-22
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIFAXIMIN PROCESS II, with a corresponding US DMF Number 33833.
Remarkably, this DMF maintains an Active status since its submission on July 22, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 03, 2019, and payment made on May 09, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
